Thyrocare Q1 profits jump 34%, revenue up 24%
Thyrocare Technologies reported a strong Q1 FY27 with consolidated revenue of ₹240 crore and net profit of ₹52.2 crore, up from ₹193 crore and ₹38.9 crore a year earlier. The results show consolidated net profit of about ₹52.2 crore on revenue of ₹240 crore, with EBITDA rising to ₹77.3 crore and margins expanding to around 32.2%, signaling healthy operating leverage. On a standalone basis, net profit rose to ₹50.17 crore, while total expenses were around ₹176.59 crore, reflecting improved cost efficiency alongside top-line growth. The board approved the unaudited standalone and consolidated results for Q1 FY27 and re-appointed Ernst & Young LLP as internal auditors for FY2026-27. Thyrocare’s performance underscores sustained momentum in diagnostic testing services within a low-cost, high-volume hub-and-spoke model, aided by franchise additions and B2B partnerships. Overall, the quarter marks robust double-digit growth in both revenue and profitability, strengthening market confidence in the organized diagnostics sector.
Where do you stand?
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Analyzing the coverage…
Where do you land?
Whose framing of this story rings truest to you?
Coverage
ae.marketscreener.comOtherThyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
businessnewsthisweek.comOtherThyrocare Reports Robust Q1FY27 Results Revenue Up 24 percent, PAT Up 34 percent
inc42.comOtherPharmEasy-Owned Thyrocare’s Q1 Profit Soars 34% To ₹51 Cr